BELSOMRA

This brand name is authorized in Japan, United States

Active ingredients

The drug BELSOMRA contains one active pharmaceutical ingredient (API):

1 Suvorexant
UNII 081L192FO9 - SUVOREXANT
Read about Suvorexant

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CJ01 N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CJ Orexin receptor antagonists
Discover more medicines within N05CJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: JP 医薬品医療機器総合機構 Identifier(s): 1190023F1024, 1190023F2020, 1190023F3027
Country: US FDA, National Drug Code Identifier(s): 0006-0005, 0006-0033, 0006-0325, 0006-0335

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.